Searched for
ARGENTINA PHARMACEUTICAL MARKET
South America to ramp up India outreach despite geographyIn an era of growing diplomatic relations, South American countries are increasingly turning to India, with Argentina leading the charge by...- Venus Remedies expands Latin America presence with Argentina nod for antibioticVenus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin Amer...
- Iran applies for membership of BRICS, Argentina also keenA series of consultations have been held regarding Tehran joining the group, claimed Iran. The spokesperson for the Iranian foreign ministr...
- India in talks with Argentina & Brazil to sign trade pactsNew Delhi already has a preferential trade agreement (PTA) with Mercosur, a trading bloc of Argentina, Brazil, Paraguay and Uruguay, but of...
- Latin American outreach: India, Argentina to expand ties in agriculture; energy; mining sectorsThe suggestions to explore untapped areas of cooperation was put forward last week by Foreign Minister at the 'India and Argentina in the N...
- Lupin appoints Martin Mercer as head of Latin American businessThe Latin American region is a market of strategic focus for the company and one of the fastest growing pharmaceutical markets globally, sh...
- Argentina opens $6 billion industry for Indian pharmaceutical companiesWith effect from August 8, the Latin American nation has included India on the list of countries that can supply medicines to it.
- Glenmark to set up first manufacturing facility in USThe proposed facility would house three units to produce oral solids, injectables and topicals and begin production by the end of the curre...
- Abbott to buy Latin American drugmaker CFR in $2.9 billion dealAbbott Lab would acquire Chile's CFR Pharma SA in a two-part, $2.9 bn deal, to double its branded generic drugs portfolio & expand in fast-...
- Lupin to replicate Japan model for expansion in various marketsLupin recently enhanced its presence in Japan with the acquisition of I'rom Pharmaceuticals in November this year for an undisclosed amount.
- Glenmark gets $25 mn from Sanofi as final upfront paymentGlenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...
- Glenmark receives $25 mn from Sanofi as upfront paymentFollowing that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...
- CRISIL assigns IPO grade 4/5 to Glenmark GenericsCRISIL has assigned IPO Grade 4/5 to the proposed IPO of Glenmark Generics Ltd, which indicates that the fundamentals of the IPO are above ...
- Lupin targets buys in Gulf, Mexico, Brazil and ArgentinaLupin Ltd. continues its buying spree with planned acquisitions in Gulf, Mexico, Brazil and Argentina.
- Glenmark plans cancer drug unit in ArgentinaMid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina.
- Mid-cap pharma firms focus on LatAm marketLupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
- IOLCP to invest Rs 216 cr, to hire 400IOL Chemicals and Pharmaceuticals Limited (IOLCP), a public listed company on Bombay Stock Exchange (BSE) and a major producer and exporter...
- Marck Biosciences plans to enter Latin American marketDrug manufacturer Marck Biosciences is planning to enter the Latin American market and has got the nod from the Brazilian healthcare watchd...
- Glenmark to reorganise biz into specialty, genericsThe new generic entity, called Glenmark Generics, will be a subsidiary of the company and will be listed on the bourses by April-June 2008-...
- Trade with Brazil to hit $10 billion in 3 monthsIndia and Brazil have set a target of increasing bilateral trade to $10 billion in three months from $2.4 billion in 2006.
Load More
